Nicoletta Loggia

Title: The Innovative Contributions of Nicoletta Loggia

Introduction: Nicoletta Loggia, an accomplished inventor based in Basel, Switzerland, has made significant strides in pharmaceutical innovations. With a focus on improving dosage forms of imatinib, her work showcases a commitment to enhancing medication delivery and patient care.

Latest Patents: Nicoletta Loggia holds a noteworthy patent titled "Melt-processed imatinib dosage form." This invention presents a dosage form comprising a melt-processed mixture of a pharmaceutically effective amount of imatinib or its salt, alongside at least one polymeric binder, and a non-ionic surfactant acceptable in pharmaceuticals. The patent emphasizes the creation of dosage forms with high drug loading capabilities, which can be efficiently prepared. It also highlights the release of the active principle in a nearly pH-independent manner, offering extended release options for imatinib.

Career Highlights: Nicoletta has worked with prestigious companies such as AbbVie Deutschland GmbH & Co. KG and Novartis AG, where she contributed her expertise in pharmaceutical development. Her experiences in these companies have shaped her innovative approach to drug formulation and delivery.

Collaborations: Throughout her career, Nicoletta has collaborated with talented individuals, including Jörg Breitenbach and Norbert Steiger. These collaborations have furthered her research and development efforts, leading to impactful advancements in drug technologies.

Conclusion: Nicoletta Loggia stands out as an innovative force in the pharmaceutical industry. Her patent on melt-processed imatinib dosage forms exemplifies her dedication to improving drug delivery systems. As she continues her work, her contributions are likely to pave the way for more effective treatments and enhanced patient outcomes in the field of pharmaceuticals.